Richard Ding — Board member

Roles

Moberg Pharma AB (publ) Stockholm
Board member
14.11.2025 – 21.08.2026

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
21.08.2026Moberg Pharma AB (publ) Stockholm
Bought — open marketAcquisition
1,000SEK 10.76
SEK 10,760.00
↗
21.08.2026Moberg Pharma AB (publ) Stockholm
SoldDisposal
48,920SEK 11.28
SEK 551,817.60
↗
18.08.2026Moberg Pharma AB (publ) Stockholm
SoldDisposal
252,327SEK 11.50
SEK 2,901,760.50
↗
13.08.2026Moberg Pharma AB (publ) Stockholm
SoldDisposal
458,055SEK 11.25
SEK 5,153,118.75
↗
16.01.2026✎Moberg Pharma AB (publ) Stockholm
SoldDisposal
46,283SEK 9.43
SEK 436,448.69
↗
16.01.2026Moberg Pharma AB (publ) Stockholm
Bought — open marketAcquisition
500SEK 9.50
SEK 4,750.00
↗
15.01.2026Moberg Pharma AB (publ) Stockholm
Bought — open marketAcquisition
500SEK 9.50
SEK 4,750.00
↗
14.01.2026✎Moberg Pharma AB (publ) Stockholm
SoldDisposal
29,556SEK 9.38
SEK 277,235.28
↗
13.01.2026Moberg Pharma AB (publ) Stockholm
SoldDisposal
27,613SEK 9.33
SEK 257,629.29
↗
21.11.2025Moberg Pharma AB (publ) Stockholm
Bought — open marketAcquisition
1,000SEK 8.22
SEK 8,215.00
↗
19.11.2025Moberg Pharma AB (publ) Stockholm
Bought — open marketAcquisition
1,600SEK 8.38
SEK 13,408.00
↗
18.11.2025Moberg Pharma AB (publ) Stockholm
Bought — open marketAcquisition
1,000SEK 8.53
SEK 8,526.00
↗
17.11.2025Moberg Pharma AB (publ) Stockholm
Bought — open marketAcquisition
5,000SEK 8.67
SEK 43,355.00
↗
14.11.2025Moberg Pharma AB (publ) Stockholm
Bought — open marketAcquisition
1,000SEK 8.99
SEK 8,990.00
↗